Debiotech has introduced, for the first time worldwide, its SOI-MEMS-based JewelPUMP platform for Diabetes Therapy at the prestigious EASD 2012 conference in Berlin, Germany

Debiotech has introduced, for the first time worldwide, its SOI-MEMS-based JewelPUMP platform for Diabetes Therapy at the prestigious EASD 2012 conference in Berlin, Germany

Following its much heralded debut at the ADA last year, Debiotech has introduced, for the first time worldwide, its SOI-MEMS-based JewelPUMP platform for Diabetes Therapy at the prestigious EASD 2012 conference in Berlin, Germany. The MEMS device was co-designed and is manufactured by STMicroelectronics. Debiotech, which also presented the results of a successful 2-year intensive study on 35 patients, is now in the stages of final development.